Search Results - "Herre, John"

Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator by Weiss, Raul, Knight, Bradley P., Gold, Michael R., Leon, Angel R., Herre, John M., Hood, Margaret, Rashtian, Mayer, Kremers, Mark, Crozier, Ian, Lee, Kerry L., Smith, Warren, Burke, Martin C.

“…BACKGROUND—The most frequent complications associated with implantable cardioverter-defibrillators (ICDs) involve the transvenous leads. A subcutaneous…”
Get full text

Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication by Boersma, Lucas V., MD, PhD, Barr, Craig S., MD, Burke, Martin C., DO, Leon, Angel R., MD, Theuns, Dominic A., PhD, Herre, John M., MD, Weiss, Raul, MD, FACS, FHRS, Kremers, Mark S., MD, FHRS, Neuzil, Petr, MD, PhD, Husby, Michael P., MS, FHRS, Carter, Nathan, MS, Stivland, Timothy M., BS, MBA, Gold, Michael R., MD, PhD

“…Background The subcutaneous implantable defibrillator (S-ICD) provides an alternative to the transvenous ICD for the prevention of sudden cardiac death, but…”
Get full text

Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry by Burke, Martin C, Gold, Michael R, Knight, Bradley P, Barr, Craig S, Theuns, Dominic A M J, Boersma, Lucas V A, Knops, Reinoud E, Weiss, Raul, Leon, Angel R, Herre, John M, Husby, Michael, Stein, Kenneth M, Lambiase, Pier D

“…The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) is the first implantable defibrillator that avoids placing electrodes in or around the…”
Get full text

Clinical outcomes of ventricular assist device support by HIV infection status: An STS-INTERMACS analysis by Birk, Sarah E, Baran, David A, Campbell, Robert, Herre, John M, Sadatsafavi, Hessam, Yehya, Amin

“…Cardiovascular disease remains the leading cause of mortality in human immunodeficiency virus-infected (HIV-positive) patients. Ventricular assist device…”
Get full text

Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System by Gold, Michael R., El-Chami, Mikhael F., Burke, Martin C., Upadhyay, Gaurav A., Niebauer, Mark J., Prutkin, Jordan M., Herre, John M., Kutalek, Steven, Dinerman, Jay L., Knight, Bradley P., Leigh, Jill, Lucas, Lindsay, Carter, Nathan, Brisben, Amy J., Aasbo, Johan D., Weiss, Raul

“…The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to avoid complications related to transvenous implantable…”
Get full text

Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results by Gold, Michael R., Aasbo, Johan D., El-Chami, Mikhael F., Niebauer, Mark, Herre, John, Prutkin, Jordan M., Knight, Bradley P., Kutalek, Steven, Hsu, Kevin, Weiss, Raul, Bass, Eric, Husby, Michael, Stivland, Timothy M., Burke, Martin C.

“…The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to reduce short- and long-term complications associated with transvenous ICD…”
Get full text

Intoxicated Donors and Heart Transplant Outcomes: Long-Term Safety by Baran, David A., Lansinger, Justin, Long, Ashleigh, Herre, John M., Yehya, Amin, Sawey, Edward J., Badiye, Amit P., Old, Wayne, Copeland, Jack, Stelling, Kelly, Copeland, Hannah

“…The opioid crisis has led to an increase in available donor hearts, although questions remain about the long-term outcomes associated with the use of these…”
Get full text

Analysis of Different Device-Based Intrathoracic Impedance Vectors for Detection of Heart Failure Events (from the Detect Fluid Early from Intrathoracic Impedance Monitoring Study) by Heist, E. Kevin, MD, PhD, Herre, John M., MD, Binkley, Philip F., MD, MPH, Van Bakel, Adrian B., MD, PhD, Porterfield, James G., MD, Porterfield, Linda M., PhD, Qu, Fujian, DSc, Turkel, Melanie, MS, Pavri, Behzad B., MD

“…Detect Fluid Early from Intrathoracic Impedance Monitoring (DEFEAT-PE) is a prospective, multicenter study of multiple intrathoracic impedance vectors to…”
Get full text

Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study by El-Chami, Mikhael F., Burke, Martin C., Herre, John M., Shah, Manish H., Sadhu, Ashish, Niebauer, Mark J., Kutalek, Steven P., Carter, Nathan, Gold, Michael R.

“…Patients with chronic renal disease on hemodialysis (HD) have limited vascular access and are at high risk of bacteremia. The subcutaneous implantable…”
Get full text

Cardiac Resynchronization Induces Major Structural and Functional Reverse Remodeling in Patients With New York Heart Association Class I/II Heart Failure by ST. JOHN SUTTON, Martin, GHIO, Stefano, LINDE, Cecilia, PLAPPERT, Ted, TAVAZZI, Luigi, SCELSI, Laura, DAUBERT, Claude, ABRAHAM, William T, GOLD, Michael R, HASSAGER, Christian, HERRE, John M

“…Cardiac resynchronization therapy (CRT) improves LV structure, function, and clinical outcomes in New York Heart Association class III/IV heart failure with…”
Get full text

Gastrointestinal Bleeding Rates in Left Ventricular Assist Device Population Reduced with Octreotide Utilization by Wilson, Tyler J., Baran, David A., Herre, John M., Cameron, Chad M., Yehya, Amin, Ingemi, Amanda I.

“…Patients with continuous-flow left ventricular assist devices have a high risk of gastrointestinal bleeding (GIB) and recurrent bleeding. Studies have shown…”
Get full text

Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients by McCune, Thomas R., Bray, Robert A., Baran, David A., Toepp, Angela J., Forte, Steven J., Gilgannon, Lauren T., Williams, Troy, Chen, Shirui, Sadr, Hooman, Gebel, Howard M., Herre, John M.

“…This study examined the development of new or changes in donor specific antibodies (DSA) mean-fluorescence intensity (MFI) after SARS-CoV-2 vaccination in 100…”
Get full text

The utilization and safety of apixaban for therapeutic anticoagulation in heart transplant population requiring routine endomyocardial biopsies by Lindauer, Kristen E., Ingemi, Amanda I., McMahon, Megan R., Lichvar, Alicia, Baran, David A., Cameron, Chad, Badiye, Amit, Sawey, Edward J., Old, Wayne, Yao, Andrew, Yehya, Amin, Herre, John M.

“…Purpose Routine endomyocardial (EM) biopsies pose a challenge in the management of heart transplant recipients requiring anticoagulation. Apixaban is a…”
Get full text

Protocol-based anticoagulation management for mechanical circulatory support patients can be safe and efficient by Birk, Sarah E, Ingemi, Amanda, Bourassa, Patricia, Neumann, Karl, Pine, Carly, Seigh, Mindy, Cassa, Hannah, Sullivan, Margaret, Baran, David A, Herre, John M, Yehya, Amin

“…Background: Achieving optimal anticoagulation remains a significant challenge in managing patients on left ventricular assist device (LVAD) support…”
Get full text

Heart transplant medicine: Beyond the guidelines by Herre, John M., MD

Get full text

Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with persistent myocarditis by Shaughnessy, Kerry K., BA, Bouchard, Susan M., BA, Mohr, Melinda R., MD, Herre, John M., MD, Salkey, Kimberly S., MD

“…D rug r eaction with e osinophilia and s ystemic s ymptoms (DRESS) syndrome is a rare serious adverse effect associated with a variety of medications. We…”
Get full text

Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure: A Substudy of the TRANSFORM-HF Randomized Clinical Trial by Krim, Selim R, Anand, Senthil, Greene, Stephen J, Chen, Anqi, Wojdyla, Daniel, Vilaro, Juan, Haught, Herbert, Herre, John M, Eisenstein, Eric L, Anstrom, Kevin J, Pitt, Bertram, Velazquez, Eric J, Mentz, Robert J

“…Differences in clinical profiles, outcomes, and diuretic treatment effects may exist between patients with de novo heart failure (HF) and worsening chronic HF…”
Get more information

Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator by Burke, Martin C., DO, Gold, Michael R., MD, PhD, Knight, Bradley P., MD, Barr, Craig S., MD, Theuns, Dominic A.M.J., PhD, Boersma, Lucas V.A., MD, PhD, Knops, Reinoud E., MD, Weiss, Raul, MD, Leon, Angel R., MD, Herre, John M., MD, Husby, Michael, MS, MPH, Stein, Kenneth M., MD, Lambiase, Pier D., PhD

“…Abstract Background The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) is the first implantable defibrillator that avoids placing…”
Get full text

Keys to successful cardiac resynchronization therapy by Herre, John, MD

“…Cardiac resynchronization therapy (CRT) improves functional status in selected groups of patients with heart failure and has achieved widespread use. However,…”
Get full text

Clinical Performance of the St. Jude Medical Riata Defibrillation Lead in a Large Patient Population by PORTERFIELD, JAMES G., PORTERFIELD, LINDA M., KUCK, KARL H., CORBISIERO, RAFFAELE, GREENBERG, STEVEN M., HINDRICKS, GERHARD, WAZNI, OUSSAMA, BEAU, SCOTT L., HERRE, JOHN M.

“…Clinical Performance of the St. Jude Medical Riata Defibrillation Lead in a Large Patient Population. Objective: The purpose of this large multicenter study…”
Get full text